As of January 22, 2025, Arbutus Biopharma (ABUS) has a market cap of $0.61 billion USD. According to our data, Arbutus Biopharma is ranked No.5868 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.61 B |
-1.53%
|
Dec 31, 2024 | $0.62 B |
30.80%
|
Dec 29, 2023 | $0.47 B |
7.30%
|
Dec 30, 2022 | $0.44 B |
-40.10%
|
Dec 31, 2021 | $0.74 B |
9.58%
|
Dec 31, 2020 | $0.67 B |
27.70%
|
Dec 31, 2019 | $0.53 B |
-27.42%
|
Dec 31, 2018 | $0.73 B |
-24.16%
|
Dec 29, 2017 | $0.96 B |
106.12%
|
Dec 30, 2016 | $0.46 B |
-44.94%
|
Dec 31, 2015 | $0.84 B |
-70.63%
|
Dec 31, 2014 | $2.87 B |
90.09%
|
Dec 31, 2013 | $1.51 B |
60.69%
|
Dec 31, 2012 | $0.94 B |
230.67%
|
Dec 30, 2011 | $0.28 B |
-68.09%
|
Dec 31, 2010 | $0.89 B |
2.17%
|
Dec 31, 2009 | $0.87 B |
217.24%
|
Dec 31, 2008 | $0.27 B |
-68.13%
|
Dec 31, 2007 | $0.86 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Arrowhead Pharmaceuticals
ARWR
|
$2.45 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioCryst Pharmaceuticals
BCRX
|
$1.58 B |
0.000 M
|
USA
|
Vir Biotechnology
VIR
|
$1.45 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Market Cap | = | ABUS Stock Price | * | ABUS Shares Outstanding |
= | $3.22 | * | 0.19 B | |
= | $0.61 B |